Helius Medical Technologies (HSDT)
(Delayed Data from NSDQ)
$4.50 USD
+0.06 (1.35%)
Updated Apr 26, 2024 03:37 PM ET
After-Market: $4.66 +0.16 (3.56%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum C VGM
Income Statements
Fiscal Year end for Helius Medical Technologies, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 1 | 1 | 1 | 2 |
Cost Of Goods | 1 | 0 | 0 | 0 | 1 |
Gross Profit | 0 | 0 | 0 | 0 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 12 | 16 | 18 | 15 | 25 |
Income After Depreciation & Amortization | -12 | -16 | -18 | -14 | -24 |
Non-Operating Income | 4 | 2 | 0 | 0 | 14 |
Interest Expense | 0 | 1 | 0 | 0 | 0 |
Pretax Income | -9 | -14 | -18 | -14 | -10 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -9 | -14 | -18 | -14 | -10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -9 | -14 | -18 | -14 | -10 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -12 | -15 | -18 | -14 | -24 |
Depreciation & Amortization (Cash Flow) | 0 | 1 | 0 | 1 | 0 |
Income After Depreciation & Amortization | -12 | -16 | -18 | -14 | -24 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 0.61 | 0.27 | 0.05 | 0.02 | 0.02 |
Diluted EPS Before Non-Recurring Items | -14.56 | -52.00 | -369.00 | -590.00 | -646.85 |
Diluted Net EPS (GAAP) | -14.56 | -52.00 | -369.00 | -590.00 | -646.85 |
Fiscal Year end for Helius Medical Technologies, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.13 | 0.14 | 0.26 | 0.11 |
Cost Of Goods | NA | 0.09 | 0.19 | 0.18 | 0.12 |
Gross Profit | NA | 0.04 | -0.04 | 0.07 | -0.01 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.29 | 3.11 | 3.29 | 3.80 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.25 | -3.15 | -3.22 | -3.81 |
Non-Operating Income | NA | 1.20 | -0.51 | 1.57 | 1.32 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -1.05 | -3.66 | -1.65 | -2.49 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.05 | -3.66 | -1.65 | -2.49 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.05 | -3.66 | -1.65 | -2.49 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 0.71 | 0.67 | 0.56 | 0.56 |
Diluted EPS Before Non-Recurring Items | NA | -1.47 | -5.49 | -3.00 | -4.50 |
Diluted Net EPS (GAAP) | NA | -1.57 | -5.49 | -3.00 | -4.50 |